Health
Backing pioneers who are transforming the health industry from digital therapeutics through to biotechnology.
Portfolio
As the UK’s most active health investor, Octopus Ventures is committed to a better future: for the past 18 months we’ve been researching developments in the fertility sector.
Our latest insights and news
12 Nov 2021
Why workplaces could unlock huge growth for fertility startups in Europe
Payers for fertility treatments and services have been limited, but the changing role of workplaces means this could be about to change, unlocking huge growth potential for startups.
1 Nov 2021
Our investment in Tuune
Millions of women struggle with side effects related to contraception, here’s how Tuune will solve it
20 Oct 2021
Our Investment in Imophoron
Imophoron is aiming to revolutionise the vaccine industry with its disruptive new technology.
27 Sep 2021
Our investment in Mojo
Our latest investment, Mojo is a sexual wellbeing platform for men which is providing an entirely pill free, digital solution.
11 Aug 2021
An update from the Health team
The Octopus Ventures Health team, now the UK’s leading health investor, reviews the last 24 months.
20 Jul 2021
Our investment in NanoSyrinx
Our latest investment, NanoSyrinx, is engineering protein nanosyringes
10 Jun 2021
Our investment in Overture
Who are the pioneers? Overture was co-founded by Martin Varsavsky (CEO) in 2017. Martin is a serial entrepreneur who has built and exited several…
27 Apr 2021
Changes and Trends in the US Exec Health Tech Space
Sarah Ruth Boyer hears Mariah Lang talk through the emerging recruitment changes on the US health tech horizon
27 Apr 2021
Deep Dive: Cannabis
Medicinal cannabis has clinical value but factors are holding it back in the UK
In the press
Portfolio support
Building a business is hard. So we’ve created a structure that best supports founders to face all challenges head on.